Approach to the evaluation of cardiomyopathy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006333:Heart Failure / Q000209:etiology*; D006334:Heart Function Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D014511:Uremia / Q000150:complications*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents